...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: Zenith Abstract at AACR 2017 Meeting April 1-5

SanFran, no you are not missing anything. The AACR conference is not listed on their events page. If I recall, Resverlogix and Zenith like to list events quarter by quarter. Technically, the AACR conference doesn't start until April 1, which is the start of Q2. 

BDAZ

Share
New Message
Please login to post a reply